Impact of U.S Supreme Court Patent Law on Canadian Intellectual Property and Regulatory Rights Landscape

By Bouchard, Ron A. | Health Law Journal, Annual 2007 | Go to article overview

Impact of U.S Supreme Court Patent Law on Canadian Intellectual Property and Regulatory Rights Landscape


Bouchard, Ron A., Health Law Journal


I. Introduction

Medical research, product development and public health regulation have been on the minds of Canadians lately, due in large part to an array of controversies over the safety and efficacy of marketed drugs (1) and the decision of the Supreme Court of Canada in Chaoulli regarding two-tiered medicine. (2) In addition, Canadians have by now experienced a number of situations where products were approved by the Therapeutic Products Directorate (TPD) of Health Canada, only to experience reduced or even denied access owing to cost considerations. (3) Moreover, the antennae of public interest scholars and commentators are being tweaked repeatedly over the increasing comfort level shown by the government with industry in relation to a wide array of issues relating to public health. These include, but are not limited to, the push by a number of agencies such as Industry Canada, Health Canada, the Canadian Institutes for Health Research (CIHR) and Genome Canada to engage in critical debate and policy development with industry over (1) the nature and degree of funding for medical research; (2) the importance of public-private partnerships in commercializing that research; (3) the extent of intellectual property and regulatory (IPR) rights attached to research products; and (4) the manner in which evidence of safety and efficacy is accrued and judged, given the present "front-loaded" approval regime and the potential "progressive licensing regime" for market authorization. (4) Finally, it has become commonplace in media discussions of national productivity and prosperity to focus on stimulating innovation in technology-heavy sectors, particularly in the life and medical sciences.

There are a number of reasons why patent jurisprudence handed down by the Supreme Court of the United States (SCOTUS) is important for scholars of Canadian health law and policy--or indeed for those of any other nation seeking to leverage its domestic science and technology base to enhance productivity in the global marketplace. These can be grouped into three broad categories, each of which revolves around a central focus on IPR rights. The fourth, dealing with a domestic "innovation ecology," and its relation to a global systems-based innovation ecology, is dealt with separately in a companion paper. (5)

From an economic perspective, Canada is one of the largest trading partners of the United States. (6) Even with a relatively small population of 32M and a GDP of U.S. SIT, total trade between nations was U.S. $500B in 2005. Added to this is the fact that the majority of successful Canadian small and medium sized enterprises (SMEs) in the biomedical industry typically have some form of venture capital funding from U.S. firms. (7) Thus, foreign sources of capital, particularly those from out largest and most valuable trading partner, continue to be important to the success of local firms. A related issue is that of economic efficiency for Canadian firms, particularly SMEs coming out of Canadian universities. This is because the costs of patenting and patent litigation escalate dramatically to the degree there are different standards of patentability in different jurisdictions. This concern extends to the growing desire by firms and government for regulatory harmony with the United States and European Union and for deregulation generally, which has become a topic of increasing debate over the last decade via the Smart Regulations policy (8)--and in a manner more focused on medical product development owing to assertive harmonization efforts by Health Canada and Industry Canada in the context of drug approval, public-private partnerships in medical research, and IPR rights associated with food and drugs legislation and regulation. (9)

A second set of issues revolves around the importance of IPR rights to a system of state-sponsored public health. IPR rights are responsible for the determination of whether and for how long products will be protected by patent and regulatory monopolies, and thus whether they are affordable and accessible to large swaths of the public, particularly those who are not shielded from monopoly costs via health care insurance.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Impact of U.S Supreme Court Patent Law on Canadian Intellectual Property and Regulatory Rights Landscape
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.